teaser_institucional-largo

INC Research

Imprimir
PDF

ass_incWe are a therapeutically focused contract research organization with a high performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I - Phase IV programs in therapeutic areas of specialty, and in innovative pediatric and women’s health trials.

Our Trusted Process® methodology and therapeutic foresight leads our customers to more confident, better-informed drug and device development decisions.

Our Mission Statement

We are an organization composed of therapeutically-focused high performance teams led by world-class project managers and leaders, dedicated to helping our customers bring products to market in order to improve world health.

Our Core Values

1. We hold ourselves to the highest ethical standards of conduct, accepting personal and professional responsibility for our decisions and actions.

2. We encourage innovative ideas and solutions, and results oriented action through high performance teams.

3. We value, respect, and support each individual team member’s role in achieving customer and corporate objectives and provide recognition for superior performance.

4. We expect all team members to be good stewards of the company’s resources.

Regional Directors & Managers

Zieher_SilviaSilvia Zieher, MD
Executive Director, Clinical Development, Latin America

Dr. Zieher has 15 years experience in clinical research as clinical team leader, clinical development manager of a top ten pharmaceutical company in Argentina and as a CRO clinical research director and head of clinical operations for Latin America. She joined the CRO industry in 2004.

Her responsibilities have included operations and project leadership activities related to the conduct of global clinical trials and the implementation of studies in Latin America. She has had direct line management responsibility of project teams. She has contributed to the development of training, quality control activities and development of processes and SOPs at the regional and global level. She has served as the the local safety officer with pharmacovigilance responsibilities for a pharma country affiliate. Dr. Zieher contributed to the preparation of the PAHO (Pan American Health Organization) guidelines: titled: “GCP: Document of the Americas” that was published in 2005, being the FIFARMA (Latin America Global Pharma industry) representative of the GCP expert working group at PANDRH (Pan American Network for Drug Regulatory Harmonization). This guideline is the foundation of all new regulations in Latin America. She has conducted academic activities in clinical research and is a frequent presenter as international conferences as DIA.
< Anterior   Próximo >